Business Information for R&D and Strategic Planning

Size: px
Start display at page:

Download "Business Information for R&D and Strategic Planning"

Transcription

1 Business Information for R&D and Strategic Planning Identifying Issues and Selecting Sources Shaida Dorabjee Information Consultant Pharma-Bio-Med, Dubrovnik. 2-5 November 2008

2 Your role in the organisation Marketing the information service Reviewing and auditing the service The importance of business information

3 Business Information Understand the business To plan your strategy To provide the right service Provide R&D information to business colleagues Keep up to date with business information sources

4 The R&D business issues New therapies, biomarkers, genomics Regulatory pressures focus on safety, economic assessment Patients consumer power, ageing population Initiatives: FDA s US Critical Path Initiative and EFPIA s Innovative Medicines Initiative or EMEA s Roadmap to 2010 New R&D Strategies Investors

5 Rethinking R&D strategies Decentralise R&D Team approach Focus on disease biology Focus on disease-relevant molecular pathways Partnerships Navigating the Drug Discovery Landscape. Decision Resources March 2008

6 The changing R&D process Discovery & Pre-clinical development Clinical trials Phase I Phase II Phase III Regulatory Review Market Incremental vs breakthrough innovation Less bureaucracy more science Emphasis on post-approval studies Learn (Discovery to proof of concept) Confirm (Proof of concept to submission) Build (Discovery to proof of concept) Confirm (Provisional approval) Expand (Updated safety data and clinical outcome) Basic Research (Understanding biology and disease) Translational Research (Concept to clinical evaluation) Critical Path Research (Improving product development).

7 Investor power Traditionally financial institutions - investment banks and venture capitalists Pension funds eg Pharma Futures

8 Pharma Futures Group of three pension funds and industry representatives Dialogue to ensure that funds managed maximise value over the long term The pension funds have invested $20bn in healthcare Interest in R&D Interested in better understanding of process and productivity in Phases I and II, and quality

9 Quality Quality of the pipeline, how quality changes over time and understanding the underlying factors that affect quality. Percentage of me-too s vs novel drugs Degree of diversification of the pipeline Progression within pipeline Rates and reasons for attrition Basic R&D information is becoming key to supporting the business and for strategic planning Pharma Futures Report: Prescription for long-tern value. 2007

10 So what Who is a member of the Pharma Futures Working Group? Where do they get their R&D information from? Who are the your collaborators in the provision of this information? Where do you go to keep up to date with business information?.

11 Sources of Business Information

12 News Alerts, RSS feeds, mobile, blogs etc Google BBC News Yahoo News Moreover w.moreover.com aggregated web news and blogs service Firstword Pharma news

13 Moreover RSS feeds

14 Firstword

15 Dow Jones dowjones.com FT PRNewswire www prnewswire.com.fr.uk NewsEdge.com News and industry information (with taxonomy and tags) Dailydrugnews.com ThomsonReuters; pipeline news Pipelinereview.com R&D News and highlights Pharmalive.com Also Med Ad news and R&D Directions ReutersHealth.com Medical and healthcare news FTP or via website

16 Newsletters Scrip Newsletter BioCentury Business intelligence for Biotech and Pharma MedAdNews Part of PharmaLive family (R&D Directions) Marketletter Global pharma, generic and bio tech business news Fiercepharma and Fiercebiotech Daily monitor

17 Fiercebiotech Free newsletter, comments on articles; Research Reports eg Innovative Strategies and Models for R&D Success

18 IMS www1.imshealth.com Market Research Data Originally data collection, now analysis, solutions, and consulting Tracks over 70% global sales Covers 100 countries Information on 260 million anonymised patients Reports/services IMS Lifecycle (including R&D Focus,New Product and Patent Focus) IMS World Review IMS Knowledge Link (sales, company and R&D info)

19 Business Information Frost & Sullivan frost.com Company and industry reports Research and marketing services Eg Globalisation of clinical trials Datamonitor datamonitor.com Data analysis and forecasting Briefings Reports Eg The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma

20 Decision Resources decisionresources.com > 150 reports each year. Specific diseases or areas and analysis of key issues facing the biopharmaceutical industry today Eg Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D EvaluatePharma evaluatepharma.com Forecasting and analysis 900 companies R&D to market Eg World Review 2012 Part of Informa

21 EvaluatePharma Plus Financial data, News releases etc

22 Market Research Reports Mindbranch.com Researchandmarkets.com Marketresearch.com Piribo.com Online business intelligence for the Biopharma industry Reports. Espicom.com Aggregators Pharmaceuticals and Devices business intelligence Market research reports

23 Piribo

24 Business/Economics The Economist Analysis of world business and current affairs, insight and opinion on international news, finance, science and technology. Surveys, Country reports, Backgrounders. Practical guides and dictionary of business terms E.I.U. Country, industry and management analysis Business Monitor International global emerging markets, plus pharma sector

25 Company information Dun & Bradstreet Dun Business information for credit, marketing and purchasing decisions worldwide KBE Key British Enterprises (ekbe); Who Owns Whom (ewow) Bureau van Dijk bvdep.com 7 million companies in Europe ICC International icc.co.uk 22 million European companies Company directories Eg Major Pharmaceutical & Biotechnology Companies of the World 2008 via

26 Information on Company web sites Investor Information Share info, shareholder info, Stock information, SEC filings, financial results, Annual Report, pipeline info Media Section News, archives, photo library (people and locations)

27 Quality Sources used Up to date Verified with originator Benchmark against best practice Re-used information

28 CMR International 2008 Pharmaceutical R&D Fact Book Parexel Bio/Pharma R&D Statistical Sourcebook 2008/2009 OECD OECD Health Data 2008 Health at a Glance WHO Statistical Information System Facts and Figures

29 OECD Heath publications

30 WHO Health Indicators.

31 Consultants PWC eg Pharma 2020: Virtual R&D - Which path will you take? Decision Resources Consulting Pharma and healthcare only BCG Ernst &Young Annual Global Pharmaceutical and Biotech Reports Accenture IBM Business Consulting Focus on IT productivity and processes White papers eg Using high performance computing clusters to accelerate life science solutions ; Pharma 2010: the threshold of innovation

32 Business Information and MR Organisations European Society for Opinion and Market Research (ESOMAR) Training, guidelines Market Research Society (MRS) Code of Conduct, training, events etc SCIP Society for Competitive Intelligence Professionals Institute for Competitive Intelligence UK, USA, Germany

33 Pharmaceutical Marketing Research Group (PMRG) Meetings, newsletter etc EphRMA European Pharmaceutical Market Research Association BHBIA British Healthcare Business Intelligence Organisation PBIRG Pharmaceutical Business Intelligence Research Group

34 Search Engines, Portals and Directories Alacra.com/alacrasearch 100 business information databases Scirus.com Scientific information search engine Vascoda.de Portal for scientific information (medpilot.de - DIMDI and German NLM) Bubl.co.uk Selected internet resources Evaluated Intute.ac.uk Web resources for education and research Evaluated

35 Alacra.com

36 Alacrawiki.com Guide to business information companies, publishers and databases

37 BUBL.co.uk (business research)

38 Intute.ac.uk (Health statistics)

39 Scirus.com

40 For the Info Pro Business Information Review journal devoted entirely to the practice of business information provision sagepub.com. VIP Business Information digital magazine that includes in-depth product reviews and comparisons, interviews with senior information industry figures and monitoring of research to identify future trends Vivavip.com Business Information Searcher quarterly publication for business information professionals, CI and knowledge managers written by acknowledged information professionals. dataresources.co.uk

41 The benefits Better awareness and understanding of your business Forge closer links with other providers of information Raise your profile within the organisation Take a more active role within the organisation

42 Thank you Shaida Dorabjee

Biomedical Business: Current Trends, Product Challenges and Future Outlook

Biomedical Business: Current Trends, Product Challenges and Future Outlook Biomedical Business: Current Trends, Product Challenges and Future Outlook Prepared and Presented by Audrey S. Erbes, Ph.D. Principal, Erbes & Associates Life Science Marketing and Business Development

More information

Introducing MintAustralia

Introducing MintAustralia Introducing MintAustralia Your Market Intelligence Platform MintAustralia is a powerful online solution delivering more valuable company and market information on Australian private and public businesses

More information

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q 2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Reference Code: GBIHC088MR Publication Date: June 2011 Biopharmaceutical companies

More information

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge

More information

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the

More information

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken. Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013 Achieving Regulatory Success: Areas of focus for biotechnology companies Michael J. Schlosser, PhD, DABT April 21, 2013 Regulatory Success Outline Regulatory Initiatives Regulatory Science Pre-Regulatory

More information

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics John D Antonio Practice Leader, Licensing & Competitive Intelligence About Paragon We help increase asset value from

More information

Xarelto-Drug Insights,2014

Xarelto-Drug Insights,2014 Brochure More information from http://www.researchandmarkets.com/reports/2977191/ Xarelto-Drug Insights,2014 Description: Xarelto - Drug Insights, 2014 provides Xarelto marketed details and API Manufacturers

More information

Orphan Pharma: pathfinders for an increasingly specialised industry

Orphan Pharma: pathfinders for an increasingly specialised industry Orphan Pharma: pathfinders for an increasingly specialised industry Foreword We are continuing our series by profiling the R&D and Clinical Development leadership of European and North American specialty

More information

e-clinical Trial Solutions Market to 2018

e-clinical Trial Solutions Market to 2018 e-clinical Trial Solutions Market to 2018 Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies GBI Research Report Guidance

More information

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies NEC3-52 November 2014 Contents

More information

2013 ICT Enterprise Insights in the Life Sciences Industry

2013 ICT Enterprise Insights in the Life Sciences Industry 2013 ICT Enterprise Insights in the Life Sciences Industry Key findings from the 2013 survey results Reference Code: IT010-000185 Publication Date: 03 Oct 2013 Author: Andrew Brosnan SUMMARY Catalyst The

More information

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010 U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction

More information

Careers in Medical and Scientific Writing

Careers in Medical and Scientific Writing Careers in Medical and Scientific Writing Laura McCormick, PhD Vice President Associate Practice Leader Tamara Fink, PhD Associate Scientific Director ProEd Communications, Inc Beachwood, Ohio Agenda Introduction

More information

How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer

How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer Applying Big Data approaches to Competitive Intelligence challenges THOMSON REUTERS IP & SCIENCE PHARMA CI EUROPE CONFERENCE & EXHIBITION TIM MILLER 19 FEBRUARY 2014 BIG DATA, NOT JUST ABOUT VOLUMES Patient

More information

Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment,

Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, Brochure More information from http://www.researchandmarkets.com/reports/2980507/ Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Description: Iron Deficiency

More information

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases Scott Johnson CEO, President and Founder Introduction Broken system of medical research No fault, system

More information

Cost of Developing a New Drug

Cost of Developing a New Drug Tufts Center for the Study of Drug Development Briefing Cost of Developing a New Drug November 18, 2014 E-mail: csdd@tufts.edu Twitter: @TuftsCSDD #TuftsCostStudy Phone: 617-636-2170 Innovation in the

More information

PharmaPendium. The definitive source of best-in-class drug information

PharmaPendium. The definitive source of best-in-class drug information Please contact us for more information Americas E-Customer Service 360 Park Avenue South New York, NY 10010-1710 USA Tel: +1 888 615 4500 (+1 212 462 1978, if calling from outside the USA and Canada) Fax:

More information

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy

More information

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners Agile Master Data Management TM : Data Governance in Action A whitepaper by First San Francisco Partners First San Francisco Partners Whitepaper Executive Summary What do data management, master data management,

More information

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology

More information

Europe Rheumatoid Arthritis Market Highlights - 2015

Europe Rheumatoid Arthritis Market Highlights - 2015 Brochure More information from http://www.researchandmarkets.com/reports/3447138/ Europe Rheumatoid Arthritis Market Highlights - 2015 Description: The latest research, 'Europe Rheumatoid Arthritis Market

More information

Quality by Design Concept

Quality by Design Concept 3rd Jerusalem Conference on Quality and Pharma Sciences 6-7 June, 2012 QbD in Clinical Research - Where Can QbD Impact Clinical Research Practices? Dr. Yafit Stark Vice President, TEVA Pharmaceutical Industries,

More information

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE University of Cambridge: Programme Specifications Every effort has been made to ensure the accuracy of the information in this programme specification. Programme specifications are produced and then reviewed

More information

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements November 2015 Presented by: Stephen Thau 2 BIOTECH IPOS ARE HOT! The Biggest Biotech

More information

Account Management in times of economic crisis

Account Management in times of economic crisis Account Management in times of economic crisis Isabel Jäckle Key Account Manager Vetter Pharma International GmbH DHBW - Ravensburger Industriegespräche October 19, 2010 Agenda Introduction of the speaker

More information

OPKO Health to Acquire Bio-Reference Laboratories

OPKO Health to Acquire Bio-Reference Laboratories OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition

More information

Company Presentation

Company Presentation Company Presentation DISCLAIMER This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and asset situation of amp biosimilars

More information

A COORDINATED SCREENING AND MANAGEMENT SYSTEM FOR EFFECTIVE LARGE-SCALE LITERATURE MONITORING

A COORDINATED SCREENING AND MANAGEMENT SYSTEM FOR EFFECTIVE LARGE-SCALE LITERATURE MONITORING A COORDINATED SCREENING AND MANAGEMENT SYSTEM FOR EFFECTIVE LARGE-SCALE LITERATURE MONITORING MEETING PHARMACOVIGILANCE AND MEDICAL DEVICE POST-MARKET SURVEILLANCE REQUIREMENTS CONTENTS 1. The fundamentals

More information

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover The rocky way from science to market Dr. Karsten Fischer BioMedPartners AG VPM Days Hannover November 2013 Content I. Stage 1 II. Setbacks 6 III. Hope 12 IV. Solutions 17 V. Expertise 20 Page 1 The Challenge

More information

Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022

Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022 Brochure More information from http://www.researchandmarkets.com/reports/2152222/ Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022 Description: Xarelto (Atrial Fibrillation) Analysis and

More information

Market Assessment Guide For Research Staff

Market Assessment Guide For Research Staff Market Assessment Guide For Research Staff Dr Ciara Leonard, OVPI, Updated June 2012 Page 1 of 6 This market assessment guide for researchers aims to provide an understanding of: 1. Why market research

More information

TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition

TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition SUMMARY OF SALIENT POINTS Importance and Competitiveness of the Ethical Pharmaceutical Industry Government

More information

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization

More information

BEST PRACTICES RESEARCH

BEST PRACTICES RESEARCH 2013 Frost & Sullivan 1 We Accelerate Growth Entrepreneurial Company of the Year Award Pharmaceutical Knowledge Process Outsourcing North America, 2013 Frost & Sullivan s Global Research Platform Frost

More information

Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada

Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D Globalization of Clinical Research: Trends & Implications for Success Rates by Phase and Therapeutic Area Source: Nature Reviews Drug

More information

Gauging the Biosimilar Effect: will the market boom or bust?

Gauging the Biosimilar Effect: will the market boom or bust? Brochure More information from http://www.researchandmarkets.com/reports/2041781/ Gauging the Biosimilar Effect: will the market boom or bust? Description: It was supposed to be the epoch of biosimilars,

More information

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

Product Life Cycle Management in Life Sciences Industry

Product Life Cycle Management in Life Sciences Industry Life Cycle Management in Life Sciences Industry Evolving from siloed to cross-functional management Audit. Tax. Consulting. Corporate Finance. A need for Lifecycle Management Life Sciences companies are

More information

Call for Demonstrator Projects

Call for Demonstrator Projects Association of the British Pharmaceutical Industry 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT t +44 (0)870 890 4333 www.abpi.org.uk Call for Demonstrator Projects ABPI Big Data Demonstrators

More information

An Introduction to Genomics and SAS Scientific Discovery Solutions

An Introduction to Genomics and SAS Scientific Discovery Solutions An Introduction to Genomics and SAS Scientific Discovery Solutions Dr Karen M Miller Product Manager Bioinformatics SAS EMEA 16.06.03 Copyright 2003, SAS Institute Inc. All rights reserved. 1 Overview!

More information

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis

Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of

More information

Outlook of China Biopharmaceutical Outsourcing Market

Outlook of China Biopharmaceutical Outsourcing Market 中 国 生 物 医 药 外 包 市 场 前 景 分 析 Outlook of China Biopharmaceutical Outsourcing Market JZMed, Inc. Report Description Attracted by the fast growth of the Chinese biopharmaceutical market as well as the thriving

More information

2011-2015. Sample-Global Big Data Market in the Healthcare Sector. technavio insights

2011-2015. Sample-Global Big Data Market in the Healthcare Sector. technavio insights 1 technavio insights About TechNavio Technavio is the research platform of Infiniti Research. Infiniti Research provides actionable market intelligence to leading companies worldwide. A team of 120 analysts

More information

www.euraxess.org.uk EURAXESS Event 28th March 2011

www.euraxess.org.uk EURAXESS Event 28th March 2011 www.euraxess.org.uk EURAXESS Event 28th March 2011 Outline EURAXESS overview Other British Council work EU projects Internationalising Higher Education Online resources Background EURAXESS is a unique

More information

Big Data An Opportunity or a Distraction? Signal or Noise?

Big Data An Opportunity or a Distraction? Signal or Noise? Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28

More information

Introduction to Bureau Van Dijk

Introduction to Bureau Van Dijk Introduction to Bureau Van Dijk Introduction to Bureau Van Dijk Who we are? Founded in 1970, with head-quarters in Brussels, Belgium. Leading European publisher of corporate financial information. 24 offices

More information

Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper

Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper Introduction The pharmaceutical industry (Pharma) has made important contributions to quality of life, longevity, economic

More information

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary MSc program Peter Heegaard, Head of Studies DTU Veterinary There is a need for Pharma graduates Pharma industry in its widest sense (see next slide) Research institutions (public and private) Consultants

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR)

Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR) Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR) Enable Science in silico & Provide the Right Knowledge to the Right People at the Right Time to enable the

More information

CLINICAL DEVELOPMENT OPTIMIZATION

CLINICAL DEVELOPMENT OPTIMIZATION PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP

More information

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Global regulatory affairs role in the biopharmaceutical industry

Global regulatory affairs role in the biopharmaceutical industry CHAPTER TWO Global affairs role in the biopharmaceutical industry 2.1 Overview 2.2 Global affairs organization 2.3 Role of global affairs 2.4 Key functions and activities 2.5 Global strategy 2.6 Global

More information

Global outlook: Healthcare

Global outlook: Healthcare Global outlook: Healthcare March 2014 healthcare 1 Today s presenters Ana Nicholls Managing Editor, Industry Briefing Economist Intelligence Unit Lauren Brayshaw Marketing executive Economist Intelligence

More information

West Nile Virus Infections-Pipeline Insights, 2016

West Nile Virus Infections-Pipeline Insights, 2016 Brochure More information from http://www.researchandmarkets.com/reports/3533615/ West Nile Virus Infections-Pipeline Insights, 2016 Description: West Nile Virus Infections-Pipeline Insights, 2016 provides

More information

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Brochure More information from http://www.researchandmarkets.com/reports/3533933/ Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Description: SUMMARY The Report,

More information

Strategic Consulting Services

Strategic Consulting Services Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief

More information

Toward Acceleration of Open Innovation

Toward Acceleration of Open Innovation Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

Nanomedicine in Horizon 2020

Nanomedicine in Horizon 2020 Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies heico.frima@ec.europa.eu ETPN Annual Event 2014

More information

MRS CPD PROGRAMME ACCREDITATION FOR BHBIA TRAINING COURSES AND WEBINARS. STANDARD 5: Project management (including planning and the use of resources)

MRS CPD PROGRAMME ACCREDITATION FOR BHBIA TRAINING COURSES AND WEBINARS. STANDARD 5: Project management (including planning and the use of resources) MRS CPD PROGRAMME ACCREDITATION FOR BHBIA TRAINING COURSES AND WEBINARS Title From Inception to Insight How effective fieldwork management is the key to success Course Date and Type Webinar 15 th January

More information

Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles

Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Neurosciences, sciences cognitives, neurologie, psychiatrie Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Technologie pour la santé 1 NEUROSCIENCE MEDICAL CHALLENGES

More information

Emerging Clinical Sites: India and China. Patrycja Doba, Clinical Research Coordinator

Emerging Clinical Sites: India and China. Patrycja Doba, Clinical Research Coordinator Emerging Clinical Sites: India and China Patrycja Doba, Clinical Research Coordinator Overview 1. Outsourcing trends in Pharmaceutical Industry 2. Reasons for outsourcing 3. The most outsourced activity

More information

White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION

White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION Table of Contents 1. Healthcare Landscape in Poland... 3 2. Clinical Research Activity in Poland... 3 3. References... 6 4. About the Author... 6

More information

A career on the science park

A career on the science park A career on the science park Onno van de Stolpe December 2014 Copyright 2014 Galapagos NV 1987 MOGEN Agricultural biotech pioneer Design of transgenic plants with improved traits Close link with Prof Schilperoort

More information

Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module

Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module Brochure More information from http://www.researchandmarkets.com/reports/2583544/ Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module Description: What the future holds: Over the next few years,

More information

Elements for optimising Orphan drug development industry perspective

Elements for optimising Orphan drug development industry perspective Elements for optimising Orphan drug development industry perspective IRDiRC Conference, Dublin, 17 April 2013 Wills Hughes-Wilson, Vice President External Affairs, Chief Patient Access Officer, Sobi With

More information

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Brochure More information from http://www.researchandmarkets.com/reports/3070277/ Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of

More information

Brochure More information from http://www.researchandmarkets.com/reports/3503782/

Brochure More information from http://www.researchandmarkets.com/reports/3503782/ Brochure More information from http://www.researchandmarkets.com/reports/3503782/ Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and

More information

Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015

Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015 Brochure More information from http://www.researchandmarkets.com/reports/3070278/ Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of

More information

Transforming relationships Unleashing innovation

Transforming relationships Unleashing innovation Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries

More information

Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)

Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus) STRATEGY FOCUS Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus) A strategic sales model for BI solutions in Big Pharma and Biotech Reference Code: BFTC1675

More information

Global Haemophilia Epidemiology and Patient Flow Analysis - 2015

Global Haemophilia Epidemiology and Patient Flow Analysis - 2015 Brochure More information from http://www.researchandmarkets.com/reports/3070298/ Global Haemophilia Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of its Haemophilia

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

Battelle Battelle s Technology Partnership Practice (TPP) Pharmaceutical Research and Manufacturers of America (PhRMA)

Battelle Battelle s Technology Partnership Practice (TPP) Pharmaceutical Research and Manufacturers of America (PhRMA) Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development,

More information

Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020

Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020 Brochure More information from http://www.researchandmarkets.com/reports/3291836/ Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020 Description: E-clinical solution

More information

Keys to success in multi-channel marketing in Japan

Keys to success in multi-channel marketing in Japan Keys to success in multi-channel marketing in Japan Abstract In the US and Europe, we have seen a drastic decline in the number of MRs and a rapid shift towards non-traditional multi-channel marketing

More information

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS 1 Table of Contents Table of Contents...1 The challenge... 2 The solution... 2 WHAT CAN YOU DO WITH

More information

Multiple Sclerosis Treatments: World Market Outlook to 2011

Multiple Sclerosis Treatments: World Market Outlook to 2011 Brochure More information from http://www.researchandmarkets.com/reports/2860814/ Multiple Sclerosis Treatments: World Market Outlook to 2011 Description: Multiple sclerosis (MS) is a chronic demyelinating

More information

Accessible intelligence for decision makers

Accessible intelligence for decision makers Pharmaceutical Market Europe Accessible intelligence for decision makers PHarMaceuticaL MarKet europe Pharmaceutical Market Europe (PME) is a trusted source for decision makers and influencers in the pharma

More information

Insulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020

Insulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020 Brochure More information from http://www.researchandmarkets.com/reports/2075322/ Insulin Degludec (Type 2 Diabetes) - Analysis and Forecasts to 2020 Description: Insulin Degludec (Type 2 Diabetes) Analysis

More information

IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope

IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope IPROVE IN BRIEF What is IPROVE? Whydo we need IPROVE? IPROVE in actions (How?) Partnership (Who?) WHAT An EU project (FP7) financed by the

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight

More information

Valuations. The Effect of the Credit Crunch, US Healthcare Reform and the Shortage of New Innovative Products. Medius Associates.

Valuations. The Effect of the Credit Crunch, US Healthcare Reform and the Shortage of New Innovative Products. Medius Associates. Licensing Valuations Deal The Effect of the Credit Crunch, US Healthcare Reform and the Shortage of New Innovative Products Medius Associates Roger Davies This article was borne from personal experience

More information

Project Management. Dissemination and Exploitation Services in Horizon 2020

Project Management. Dissemination and Exploitation Services in Horizon 2020 Project Management Dissemination and Exploitation Services in Horizon 2020 Ontwerp: Studio Edwin de Boer 2 Project Management Dissemination and Exploitation Services in Horizon 2020 ttopstart - Project

More information

SILOBREAKER ENTERPRISE SOFTWARE SUITE

SILOBREAKER ENTERPRISE SOFTWARE SUITE INSIGHT AS A SERVICE SILOBREAKER ENTERPRISE SOFTWARE SUITE Fully customizable behind your firewall! Silobreaker Enterprise Software Suite is Silobreaker s flagship product. It is ideal for organizations

More information

Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Brochure More information from http://www.researchandmarkets.com/reports/2228475/ Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Description: Avastin (Renal Cell Carcinoma) Analysis and

More information

Xarelto-API Insights. Brochure More information from http://www.researchandmarkets.com/reports/3043740/

Xarelto-API Insights. Brochure More information from http://www.researchandmarkets.com/reports/3043740/ Brochure More information from http://www.researchandmarkets.com/reports/3043740/ Xarelto-API Insights Description: Summary The active pharmaceutical ingredients worldwide market is in continuous development

More information

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts. Brochure More information from http://www.researchandmarkets.com/reports/1882193/ Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising

More information

APAC Contract Research Organisation (CRO) Market

APAC Contract Research Organisation (CRO) Market Brochure More information from http://www.researchandmarkets.com/reports/3308444/ APAC Contract Research Organisation (CRO) Market Description: The research service presents an overview and analysis of

More information

Life Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com

Life Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com Life Science Sector Opportunities Northern Ireland investni.com Introduction Clinical trials commonly refer to testing the effectiveness of experimental drugs and are typically categorised into four phases;

More information

2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities. Study Fast Facts

2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities. Study Fast Facts 2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities Study Fast Facts December 18 th 2015 SURVEY BACKGROUND Gens & Associates Life Science research projects are renowned for

More information